The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions.
D001132:Arm / Q000098:blood supply; D001161:Arteriosclerosis / Q000503:physiopathology; D001809:Blood Viscosity / Q000187:drug effects; D002936:Cinnarizine / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000503:physiopathology; D004311:Double-Blind Method; D004910:Erythrocyte Membrane / Q000187:drug effects; D006801:Humans; D007511:Ischemia / Q000503:physiopathology; D009203:Myocardial Infarction / Q000503:physiopathology; D009994:Osmolar Concentration; D010879:Piperazines / Q000494:pharmacology*; D012212:Rheology; D014665:Vasodilator Agents / Q000494:pharmacology*
D010879:Piperazines; D014665:Vasodilator Agents; D002936:Cinnarizine